Pharma & Healthcare
Global Irritable Bowel Syndrome (IBS) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Apr 07, 25
- ID: 177967
- Pages: 80
- Figures: 79
- Views: 7
The global Irritable Bowel Syndrome (IBS) market size was US$ 6252 million in 2024 and is forecast to a readjusted size of US$ 16410 million by 2031 with a CAGR of 15.0% during the forecast period 2025-2031.
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
North America is the largest region of Irritable Bowel Syndrome (IBS), with a market share about 75%. Allergan, Valeant Pharmaceuticals, Takeda, Sucampo Pharmaceuticals and McNeil Consumer Healthcare are the top 5 manufacturers of industry, and they had about 80% combined market share.
The global Irritable Bowel Syndrome (IBS) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Bausch Health
Allergan
Takeda
Sucampo Pharmaceuticals (Mallinckrodt)
Sebela Pharmaceuticals Inc
Astellas Pharmaceuticals
By Type: (Dominant Segment vs High-Margin Innovation)
IBS-D Drug
IBS-C Drug
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Women
Men
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Bausch Health in Europe)
- Emerging Product Trends: IBS-D Drug adoption vs. IBS-C Drug premiumization
- Demand-Side Dynamics: Women growth in China vs. Men potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Irritable Bowel Syndrome (IBS) market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., IBS-C Drug in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Men in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Irritable Bowel Syndrome (IBS) value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
North America is the largest region of Irritable Bowel Syndrome (IBS), with a market share about 75%. Allergan, Valeant Pharmaceuticals, Takeda, Sucampo Pharmaceuticals and McNeil Consumer Healthcare are the top 5 manufacturers of industry, and they had about 80% combined market share.
The global Irritable Bowel Syndrome (IBS) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Bausch Health
Allergan
Takeda
Sucampo Pharmaceuticals (Mallinckrodt)
Sebela Pharmaceuticals Inc
Astellas Pharmaceuticals
By Type: (Dominant Segment vs High-Margin Innovation)
IBS-D Drug
IBS-C Drug
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Women
Men
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Bausch Health in Europe)
- Emerging Product Trends: IBS-D Drug adoption vs. IBS-C Drug premiumization
- Demand-Side Dynamics: Women growth in China vs. Men potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Irritable Bowel Syndrome (IBS) market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., IBS-C Drug in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Men in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Irritable Bowel Syndrome (IBS) value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 IBS-D Drug
1.2.3 IBS-C Drug
1.2.4 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Women
1.3.3 Men
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Irritable Bowel Syndrome (IBS) Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Region (2020-2025)
2.4 Global Irritable Bowel Syndrome (IBS) Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Irritable Bowel Syndrome (IBS) Market Size and Prospective (2020-2031)
2.5.2 Europe Irritable Bowel Syndrome (IBS) Market Size and Prospective (2020-2031)
2.5.3 Japan Irritable Bowel Syndrome (IBS) Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Type (2020-2025)
3.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Type (2026-2031)
3.3 Different Types Irritable Bowel Syndrome (IBS) Representative Players
4 Breakdown Data by Application
4.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Application (2020-2025)
4.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Irritable Bowel Syndrome (IBS) Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Irritable Bowel Syndrome (IBS) Players by Revenue (2020-2025)
5.1.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Irritable Bowel Syndrome (IBS) Revenue
5.4 Global Irritable Bowel Syndrome (IBS) Market Concentration Analysis
5.4.1 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome (IBS) Revenue in 2024
5.5 Global Key Players of Irritable Bowel Syndrome (IBS) Head office and Area Served
5.6 Global Key Players of Irritable Bowel Syndrome (IBS), Product and Application
5.7 Global Key Players of Irritable Bowel Syndrome (IBS), Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Irritable Bowel Syndrome (IBS) Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Irritable Bowel Syndrome (IBS) Market Size by Type (2020-2025)
6.1.2.2 North America Irritable Bowel Syndrome (IBS) Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Irritable Bowel Syndrome (IBS) Market Size by Application (2020-2025)
6.1.3.2 North America Irritable Bowel Syndrome (IBS) Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Irritable Bowel Syndrome (IBS) Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2020-2025)
6.2.2.2 Europe Irritable Bowel Syndrome (IBS) Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2020-2025)
6.2.3.2 Europe Irritable Bowel Syndrome (IBS) Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 Japan Market: Players, Segments and Downstream
6.3.1 Japan Irritable Bowel Syndrome (IBS) Revenue by Company (2020-2025)
6.3.2 Japan Market Size by Type
6.3.2.1 Japan Irritable Bowel Syndrome (IBS) Market Size by Type (2020-2025)
6.3.2.2 Japan Irritable Bowel Syndrome (IBS) Market Share by Type (2020-2025)
6.3.3 Japan Market Size by Application
6.3.3.1 Japan Irritable Bowel Syndrome (IBS) Market Size by Application (2020-2025)
6.3.3.2 Japan Irritable Bowel Syndrome (IBS) Market Share by Application (2020-2025)
6.3.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Bausch Health
7.1.1 Bausch Health Company Details
7.1.2 Bausch Health Business Overview
7.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Introduction
7.1.4 Bausch Health Revenue in Irritable Bowel Syndrome (IBS) Business (2020-2025)
7.1.5 Bausch Health Recent Development
7.2 Allergan
7.2.1 Allergan Company Details
7.2.2 Allergan Business Overview
7.2.3 Allergan Irritable Bowel Syndrome (IBS) Introduction
7.2.4 Allergan Revenue in Irritable Bowel Syndrome (IBS) Business (2020-2025)
7.2.5 Allergan Recent Development
7.3 Takeda
7.3.1 Takeda Company Details
7.3.2 Takeda Business Overview
7.3.3 Takeda Irritable Bowel Syndrome (IBS) Introduction
7.3.4 Takeda Revenue in Irritable Bowel Syndrome (IBS) Business (2020-2025)
7.3.5 Takeda Recent Development
7.4 Sucampo Pharmaceuticals (Mallinckrodt)
7.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Company Details
7.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
7.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Introduction
7.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Revenue in Irritable Bowel Syndrome (IBS) Business (2020-2025)
7.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Development
7.5 Sebela Pharmaceuticals Inc
7.5.1 Sebela Pharmaceuticals Inc Company Details
7.5.2 Sebela Pharmaceuticals Inc Business Overview
7.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Introduction
7.5.4 Sebela Pharmaceuticals Inc Revenue in Irritable Bowel Syndrome (IBS) Business (2020-2025)
7.5.5 Sebela Pharmaceuticals Inc Recent Development
7.6 Astellas Pharmaceuticals
7.6.1 Astellas Pharmaceuticals Company Details
7.6.2 Astellas Pharmaceuticals Business Overview
7.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Introduction
7.6.4 Astellas Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2020-2025)
7.6.5 Astellas Pharmaceuticals Recent Development
8 Irritable Bowel Syndrome (IBS) Market Dynamics
8.1 Irritable Bowel Syndrome (IBS) Industry Trends
8.2 Irritable Bowel Syndrome (IBS) Market Drivers
8.3 Irritable Bowel Syndrome (IBS) Market Challenges
8.4 Irritable Bowel Syndrome (IBS) Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 IBS-D Drug
1.2.3 IBS-C Drug
1.2.4 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Women
1.3.3 Men
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Irritable Bowel Syndrome (IBS) Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Region (2020-2025)
2.4 Global Irritable Bowel Syndrome (IBS) Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Irritable Bowel Syndrome (IBS) Market Size and Prospective (2020-2031)
2.5.2 Europe Irritable Bowel Syndrome (IBS) Market Size and Prospective (2020-2031)
2.5.3 Japan Irritable Bowel Syndrome (IBS) Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Type (2020-2025)
3.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Type (2026-2031)
3.3 Different Types Irritable Bowel Syndrome (IBS) Representative Players
4 Breakdown Data by Application
4.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Application (2020-2025)
4.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Irritable Bowel Syndrome (IBS) Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Irritable Bowel Syndrome (IBS) Players by Revenue (2020-2025)
5.1.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Irritable Bowel Syndrome (IBS) Revenue
5.4 Global Irritable Bowel Syndrome (IBS) Market Concentration Analysis
5.4.1 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome (IBS) Revenue in 2024
5.5 Global Key Players of Irritable Bowel Syndrome (IBS) Head office and Area Served
5.6 Global Key Players of Irritable Bowel Syndrome (IBS), Product and Application
5.7 Global Key Players of Irritable Bowel Syndrome (IBS), Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Irritable Bowel Syndrome (IBS) Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Irritable Bowel Syndrome (IBS) Market Size by Type (2020-2025)
6.1.2.2 North America Irritable Bowel Syndrome (IBS) Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Irritable Bowel Syndrome (IBS) Market Size by Application (2020-2025)
6.1.3.2 North America Irritable Bowel Syndrome (IBS) Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Irritable Bowel Syndrome (IBS) Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2020-2025)
6.2.2.2 Europe Irritable Bowel Syndrome (IBS) Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2020-2025)
6.2.3.2 Europe Irritable Bowel Syndrome (IBS) Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 Japan Market: Players, Segments and Downstream
6.3.1 Japan Irritable Bowel Syndrome (IBS) Revenue by Company (2020-2025)
6.3.2 Japan Market Size by Type
6.3.2.1 Japan Irritable Bowel Syndrome (IBS) Market Size by Type (2020-2025)
6.3.2.2 Japan Irritable Bowel Syndrome (IBS) Market Share by Type (2020-2025)
6.3.3 Japan Market Size by Application
6.3.3.1 Japan Irritable Bowel Syndrome (IBS) Market Size by Application (2020-2025)
6.3.3.2 Japan Irritable Bowel Syndrome (IBS) Market Share by Application (2020-2025)
6.3.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Bausch Health
7.1.1 Bausch Health Company Details
7.1.2 Bausch Health Business Overview
7.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Introduction
7.1.4 Bausch Health Revenue in Irritable Bowel Syndrome (IBS) Business (2020-2025)
7.1.5 Bausch Health Recent Development
7.2 Allergan
7.2.1 Allergan Company Details
7.2.2 Allergan Business Overview
7.2.3 Allergan Irritable Bowel Syndrome (IBS) Introduction
7.2.4 Allergan Revenue in Irritable Bowel Syndrome (IBS) Business (2020-2025)
7.2.5 Allergan Recent Development
7.3 Takeda
7.3.1 Takeda Company Details
7.3.2 Takeda Business Overview
7.3.3 Takeda Irritable Bowel Syndrome (IBS) Introduction
7.3.4 Takeda Revenue in Irritable Bowel Syndrome (IBS) Business (2020-2025)
7.3.5 Takeda Recent Development
7.4 Sucampo Pharmaceuticals (Mallinckrodt)
7.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Company Details
7.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
7.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Introduction
7.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Revenue in Irritable Bowel Syndrome (IBS) Business (2020-2025)
7.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Development
7.5 Sebela Pharmaceuticals Inc
7.5.1 Sebela Pharmaceuticals Inc Company Details
7.5.2 Sebela Pharmaceuticals Inc Business Overview
7.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Introduction
7.5.4 Sebela Pharmaceuticals Inc Revenue in Irritable Bowel Syndrome (IBS) Business (2020-2025)
7.5.5 Sebela Pharmaceuticals Inc Recent Development
7.6 Astellas Pharmaceuticals
7.6.1 Astellas Pharmaceuticals Company Details
7.6.2 Astellas Pharmaceuticals Business Overview
7.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Introduction
7.6.4 Astellas Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2020-2025)
7.6.5 Astellas Pharmaceuticals Recent Development
8 Irritable Bowel Syndrome (IBS) Market Dynamics
8.1 Irritable Bowel Syndrome (IBS) Industry Trends
8.2 Irritable Bowel Syndrome (IBS) Market Drivers
8.3 Irritable Bowel Syndrome (IBS) Market Challenges
8.4 Irritable Bowel Syndrome (IBS) Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Irritable Bowel Syndrome (IBS) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Irritable Bowel Syndrome (IBS) Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Irritable Bowel Syndrome (IBS) Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Irritable Bowel Syndrome (IBS) Revenue Share by Region (2020-2025)
Table 6. Global Irritable Bowel Syndrome (IBS) Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Irritable Bowel Syndrome (IBS) Revenue Share Forecast by Region (2026-2031)
Table 8. Global Irritable Bowel Syndrome (IBS) Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2020-2025)
Table 10. Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Irritable Bowel Syndrome (IBS) Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2020-2025)
Table 15. Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Irritable Bowel Syndrome (IBS) Application
Table 18. Global Irritable Bowel Syndrome (IBS) Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Irritable Bowel Syndrome (IBS) Market Share by Players (2020-2025)
Table 20. Global Top Irritable Bowel Syndrome (IBS) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome (IBS) as of 2024)
Table 21. Ranking of Global Top Irritable Bowel Syndrome (IBS) Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Irritable Bowel Syndrome (IBS) Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Irritable Bowel Syndrome (IBS), Headquarters and Area Served
Table 24. Global Key Players of Irritable Bowel Syndrome (IBS), Product and Application
Table 25. Global Key Players of Irritable Bowel Syndrome (IBS), Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Irritable Bowel Syndrome (IBS) Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Company (2020-2025)
Table 29. North America Irritable Bowel Syndrome (IBS) Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Irritable Bowel Syndrome (IBS) Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Irritable Bowel Syndrome (IBS) Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Irritable Bowel Syndrome (IBS) Revenue Market Share by Company (2020-2025)
Table 33. Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2020-2025) & (US$ Million)
Table 35. Japan Irritable Bowel Syndrome (IBS) Revenue by Company (2020-2025) & (US$ Million)
Table 36. Japan Irritable Bowel Syndrome (IBS) Revenue Market Share by Company (2020-2025)
Table 37. Japan Irritable Bowel Syndrome (IBS) Market Size by Type (2020-2025) & (US$ Million)
Table 38. Japan Irritable Bowel Syndrome (IBS) Market Size by Application (2020-2025) & (US$ Million)
Table 39. Bausch Health Company Details
Table 40. Bausch Health Business Overview
Table 41. Bausch Health Irritable Bowel Syndrome (IBS) Product
Table 42. Bausch Health Revenue in Irritable Bowel Syndrome (IBS) Business (2020-2025) & (US$ Million)
Table 43. Bausch Health Recent Development
Table 44. Allergan Company Details
Table 45. Allergan Business Overview
Table 46. Allergan Irritable Bowel Syndrome (IBS) Product
Table 47. Allergan Revenue in Irritable Bowel Syndrome (IBS) Business (2020-2025) & (US$ Million)
Table 48. Allergan Recent Development
Table 49. Takeda Company Details
Table 50. Takeda Business Overview
Table 51. Takeda Irritable Bowel Syndrome (IBS) Product
Table 52. Takeda Revenue in Irritable Bowel Syndrome (IBS) Business (2020-2025) & (US$ Million)
Table 53. Takeda Recent Development
Table 54. Sucampo Pharmaceuticals (Mallinckrodt) Company Details
Table 55. Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
Table 56. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product
Table 57. Sucampo Pharmaceuticals (Mallinckrodt) Revenue in Irritable Bowel Syndrome (IBS) Business (2020-2025) & (US$ Million)
Table 58. Sucampo Pharmaceuticals (Mallinckrodt) Recent Development
Table 59. Sebela Pharmaceuticals Inc Company Details
Table 60. Sebela Pharmaceuticals Inc Business Overview
Table 61. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product
Table 62. Sebela Pharmaceuticals Inc Revenue in Irritable Bowel Syndrome (IBS) Business (2020-2025) & (US$ Million)
Table 63. Sebela Pharmaceuticals Inc Recent Development
Table 64. Astellas Pharmaceuticals Company Details
Table 65. Astellas Pharmaceuticals Business Overview
Table 66. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product
Table 67. Astellas Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2020-2025) & (US$ Million)
Table 68. Astellas Pharmaceuticals Recent Development
Table 69. Irritable Bowel Syndrome (IBS) Market Trends
Table 70. Irritable Bowel Syndrome (IBS) Market Drivers
Table 71. Irritable Bowel Syndrome (IBS) Market Challenges
Table 72. Irritable Bowel Syndrome (IBS) Market Restraints
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Irritable Bowel Syndrome (IBS) Product Picture
Figure 2. Global Irritable Bowel Syndrome (IBS) Market Share by Type: 2024 VS 2031
Figure 3. IBS-D Drug Features
Figure 4. IBS-C Drug Features
Figure 5. Others Features
Figure 6. Global Irritable Bowel Syndrome (IBS) Market Share by Application: 2024 VS 2031
Figure 7. Women
Figure 8. Men
Figure 9. Irritable Bowel Syndrome (IBS) Report Years Considered
Figure 10. Global Irritable Bowel Syndrome (IBS) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 11. Global Irritable Bowel Syndrome (IBS) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Region: 2020 VS 2024
Figure 13. North America Irritable Bowel Syndrome (IBS) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 14. Europe Irritable Bowel Syndrome (IBS) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Japan Irritable Bowel Syndrome (IBS) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Global Irritable Bowel Syndrome (IBS) Market Share by Players in 2024
Figure 17. Global Top Irritable Bowel Syndrome (IBS) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome (IBS) as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Irritable Bowel Syndrome (IBS) Revenue in 2024
Figure 19. North America Irritable Bowel Syndrome (IBS) Market Share by Type (2020-2025)
Figure 20. North America Irritable Bowel Syndrome (IBS) Market Share by Application (2020-2025)
Figure 21. Europe Irritable Bowel Syndrome (IBS) Market Share by Type (2020-2025)
Figure 22. Europe Irritable Bowel Syndrome (IBS) Market Share by Application (2020-2025)
Figure 23. Japan Irritable Bowel Syndrome (IBS) Market Share by Type (2020-2025)
Figure 24. Japan Irritable Bowel Syndrome (IBS) Market Share by Application (2020-2025)
Figure 25. Bausch Health Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2020-2025)
Figure 26. Allergan Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2020-2025)
Figure 27. Takeda Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2020-2025)
Figure 28. Sucampo Pharmaceuticals (Mallinckrodt) Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2020-2025)
Figure 29. Sebela Pharmaceuticals Inc Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2020-2025)
Figure 30. Astellas Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2020-2025)
Figure 31. Bottom-up and Top-down Approaches for This Report
Figure 32. Data Triangulation
Figure 33. Key Executives Interviewed
Table 1. Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Irritable Bowel Syndrome (IBS) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Irritable Bowel Syndrome (IBS) Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Irritable Bowel Syndrome (IBS) Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Irritable Bowel Syndrome (IBS) Revenue Share by Region (2020-2025)
Table 6. Global Irritable Bowel Syndrome (IBS) Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Irritable Bowel Syndrome (IBS) Revenue Share Forecast by Region (2026-2031)
Table 8. Global Irritable Bowel Syndrome (IBS) Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2020-2025)
Table 10. Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Irritable Bowel Syndrome (IBS) Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2020-2025)
Table 15. Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Irritable Bowel Syndrome (IBS) Application
Table 18. Global Irritable Bowel Syndrome (IBS) Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Irritable Bowel Syndrome (IBS) Market Share by Players (2020-2025)
Table 20. Global Top Irritable Bowel Syndrome (IBS) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome (IBS) as of 2024)
Table 21. Ranking of Global Top Irritable Bowel Syndrome (IBS) Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Irritable Bowel Syndrome (IBS) Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Irritable Bowel Syndrome (IBS), Headquarters and Area Served
Table 24. Global Key Players of Irritable Bowel Syndrome (IBS), Product and Application
Table 25. Global Key Players of Irritable Bowel Syndrome (IBS), Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Irritable Bowel Syndrome (IBS) Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Company (2020-2025)
Table 29. North America Irritable Bowel Syndrome (IBS) Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Irritable Bowel Syndrome (IBS) Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Irritable Bowel Syndrome (IBS) Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Irritable Bowel Syndrome (IBS) Revenue Market Share by Company (2020-2025)
Table 33. Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2020-2025) & (US$ Million)
Table 35. Japan Irritable Bowel Syndrome (IBS) Revenue by Company (2020-2025) & (US$ Million)
Table 36. Japan Irritable Bowel Syndrome (IBS) Revenue Market Share by Company (2020-2025)
Table 37. Japan Irritable Bowel Syndrome (IBS) Market Size by Type (2020-2025) & (US$ Million)
Table 38. Japan Irritable Bowel Syndrome (IBS) Market Size by Application (2020-2025) & (US$ Million)
Table 39. Bausch Health Company Details
Table 40. Bausch Health Business Overview
Table 41. Bausch Health Irritable Bowel Syndrome (IBS) Product
Table 42. Bausch Health Revenue in Irritable Bowel Syndrome (IBS) Business (2020-2025) & (US$ Million)
Table 43. Bausch Health Recent Development
Table 44. Allergan Company Details
Table 45. Allergan Business Overview
Table 46. Allergan Irritable Bowel Syndrome (IBS) Product
Table 47. Allergan Revenue in Irritable Bowel Syndrome (IBS) Business (2020-2025) & (US$ Million)
Table 48. Allergan Recent Development
Table 49. Takeda Company Details
Table 50. Takeda Business Overview
Table 51. Takeda Irritable Bowel Syndrome (IBS) Product
Table 52. Takeda Revenue in Irritable Bowel Syndrome (IBS) Business (2020-2025) & (US$ Million)
Table 53. Takeda Recent Development
Table 54. Sucampo Pharmaceuticals (Mallinckrodt) Company Details
Table 55. Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
Table 56. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product
Table 57. Sucampo Pharmaceuticals (Mallinckrodt) Revenue in Irritable Bowel Syndrome (IBS) Business (2020-2025) & (US$ Million)
Table 58. Sucampo Pharmaceuticals (Mallinckrodt) Recent Development
Table 59. Sebela Pharmaceuticals Inc Company Details
Table 60. Sebela Pharmaceuticals Inc Business Overview
Table 61. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product
Table 62. Sebela Pharmaceuticals Inc Revenue in Irritable Bowel Syndrome (IBS) Business (2020-2025) & (US$ Million)
Table 63. Sebela Pharmaceuticals Inc Recent Development
Table 64. Astellas Pharmaceuticals Company Details
Table 65. Astellas Pharmaceuticals Business Overview
Table 66. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product
Table 67. Astellas Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2020-2025) & (US$ Million)
Table 68. Astellas Pharmaceuticals Recent Development
Table 69. Irritable Bowel Syndrome (IBS) Market Trends
Table 70. Irritable Bowel Syndrome (IBS) Market Drivers
Table 71. Irritable Bowel Syndrome (IBS) Market Challenges
Table 72. Irritable Bowel Syndrome (IBS) Market Restraints
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Irritable Bowel Syndrome (IBS) Product Picture
Figure 2. Global Irritable Bowel Syndrome (IBS) Market Share by Type: 2024 VS 2031
Figure 3. IBS-D Drug Features
Figure 4. IBS-C Drug Features
Figure 5. Others Features
Figure 6. Global Irritable Bowel Syndrome (IBS) Market Share by Application: 2024 VS 2031
Figure 7. Women
Figure 8. Men
Figure 9. Irritable Bowel Syndrome (IBS) Report Years Considered
Figure 10. Global Irritable Bowel Syndrome (IBS) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 11. Global Irritable Bowel Syndrome (IBS) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Region: 2020 VS 2024
Figure 13. North America Irritable Bowel Syndrome (IBS) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 14. Europe Irritable Bowel Syndrome (IBS) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Japan Irritable Bowel Syndrome (IBS) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Global Irritable Bowel Syndrome (IBS) Market Share by Players in 2024
Figure 17. Global Top Irritable Bowel Syndrome (IBS) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome (IBS) as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Irritable Bowel Syndrome (IBS) Revenue in 2024
Figure 19. North America Irritable Bowel Syndrome (IBS) Market Share by Type (2020-2025)
Figure 20. North America Irritable Bowel Syndrome (IBS) Market Share by Application (2020-2025)
Figure 21. Europe Irritable Bowel Syndrome (IBS) Market Share by Type (2020-2025)
Figure 22. Europe Irritable Bowel Syndrome (IBS) Market Share by Application (2020-2025)
Figure 23. Japan Irritable Bowel Syndrome (IBS) Market Share by Type (2020-2025)
Figure 24. Japan Irritable Bowel Syndrome (IBS) Market Share by Application (2020-2025)
Figure 25. Bausch Health Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2020-2025)
Figure 26. Allergan Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2020-2025)
Figure 27. Takeda Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2020-2025)
Figure 28. Sucampo Pharmaceuticals (Mallinckrodt) Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2020-2025)
Figure 29. Sebela Pharmaceuticals Inc Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2020-2025)
Figure 30. Astellas Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2020-2025)
Figure 31. Bottom-up and Top-down Approaches for This Report
Figure 32. Data Triangulation
Figure 33. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232